Spark Investment Management LLC Akebia Therapeutics, Inc. Transaction History

Spark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$4.1 - $8.05 $2 Million - $3.93 Million	-488,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$5.39 - $9.15 $1.02 Million - $1.72 Million	188,500 Added 62.83%	488,500 $2.7 Million
Q3 2018 Nov 13, 2018	BUY	$7.44 - $10.65 $180,792 - $258,795	24,300 Added 8.81%	300,000 $2.65 Million
Q2 2018 Aug 08, 2018	SELL	$9.15 - $11.34 $241,560 - $299,376	-26,400 Reduced 8.74%	275,700 $2.75 Million
Q1 2018 May 10, 2018	BUY	$9.53 - $15.68 $1.77 Million - $2.91 Million	185,700 Added 159.54%	302,100 $2.88 Million
Q4 2017 Feb 12, 2018	BUY	$14.24 - $19.59 $1.2 Million - $1.66 Million	84,600 Added 266.04%	116,400 $1.73 Million
Q3 2017 Nov 13, 2017	BUY	$13.06 - $19.67 $415,308 - $625,506	31,800	31,800 $625,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $353M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.